Serous carcinoma
Serous carcinoma is a type of epithelial cancer that typically arises from the serous fluid-producing tissues, such as the ovary, fallopian tube, uterus, peritoneum, and lung. It is characterized by the presence of psammoma bodies, which are concentrically laminated, calcified structures seen under the microscope.
Epidemiology[edit | edit source]
Serous carcinoma is the most common type of ovarian cancer, accounting for about 70% of cases. It is also the most aggressive subtype, with a high rate of recurrence and resistance to chemotherapy. The median age at diagnosis is 63 years.
Pathogenesis[edit | edit source]
The pathogenesis of serous carcinoma is not fully understood. It is thought to arise from the serous epithelium of the ovary or fallopian tube, which undergoes malignant transformation due to genetic mutations. The most common mutations are in the TP53 gene, which is found in over 90% of cases.
Clinical features[edit | edit source]
Patients with serous carcinoma often present with nonspecific symptoms, such as abdominal pain, bloating, and early satiety. In advanced stages, the disease can cause ascites, pleural effusion, and peritoneal carcinomatosis.
Diagnosis[edit | edit source]
The diagnosis of serous carcinoma is based on histopathological examination of tissue obtained by surgery or biopsy. The tumor cells are typically high-grade and show complex, irregular architecture with numerous psammoma bodies.
Treatment[edit | edit source]
The treatment of serous carcinoma involves surgery to remove as much of the tumor as possible, followed by chemotherapy. The most commonly used chemotherapy regimen is a combination of paclitaxel and carboplatin.
Prognosis[edit | edit source]
The prognosis of serous carcinoma is generally poor, with a 5-year survival rate of less than 50%. Factors that influence prognosis include the stage at diagnosis, the patient's age and general health, and the response to treatment.
Serous carcinoma Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD